Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: Implications for application in clinical practice

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 3, 2008, Pages 226-232

  Bessa, Vasiliki ^a   Tseliou, Eleni ^a   Bakakos, Petros ^a   Loukides, Stelios ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 18; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE E4; MYELOPEROXIDASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; BLOOD ANALYSIS; BRONCHUS HYPERREACTIVITY; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE MARKER; EXPIRED AIR; HUMAN; MEDLINE; NEUTROPHILIA; NON INVASIVE MEASUREMENT; PH MEASUREMENT; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; SPIROMETRY; SPUTUM ANALYSIS; SUPERNATANT; URINALYSIS;

EID: 51649092146     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60485-1     Document Type: Review

References (49)

1. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report. Bethesda, MD: National Heart, Lung, and Blood Institute; 2007.
2. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J. 2004;24:822-833.
3. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun. 1991;181:852-857.
4. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet. 1994;343:133-135.
5. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163:1693-1722.
6. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163-2173.
7. Brightling CE. Clinical applications of induced sputum. Chest. 2006;129:1344-1348.
8. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;360:1715-1721.
9. Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26:523-548.
10. Montuschi P. Indirect monitoring of lung inflammation. Nat Rev Drug Discov. 2002;1:238-242.
11. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol. 2002;110:28-34.
12. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy. 2008;38:557-565.
13. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta. 2005;356:22-34.
14. Pizzichini E, Pizzichini MM, Kidney JC, et al. Induced sputum, bronchoalveoral lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared. Eur Respir J. 1998;11:828-834.
15. Grootendorst DC, Sont JK, Willems LN. Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy. 1997;27:769-779.
16. Kips JC, Fahy JV, Hargreave FE, Ind PW, in't Veen JC. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J Suppl. 1998;26:9S-12S.
17. Nightingale JA, Rogers DF, Barnes PJ. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax. 1998;53:87-90.
18. Fahy JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med. 2001;163:1470-1475.
19. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996;154:308-317.
20. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity: reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 2000;162:1172-1174.
21. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma. Chest. 2006;129:661-668.
22. Chalmers G, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120:1917-1922.
23. 4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma. Chest. 2005;127:1553-1559.
24. Zhang X, Moilanen E, Lanthi A, et al. Regulation of eosinophil apoptosis by nitric oxide: role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5. J Allergy Clin Immunol. 2003;112:93-101.
25. Yamamoto K, Takanashi S, Hasegawa Y, Kanehira Y, Kaizuka M, Okumura K. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers. Respiration. 2003;70:600-605.
26. McKay A, Komai-Koma M, MacLeod K, et al. Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers. Clin Exp Allergy. 2004;34:904-910.
27. Redington AE. Modulation of nitric oxide pathways: therapeutic potential in asthma and chronic obstructive pulmonary disease. Eur J Pharmacol. 2006;533:263-276.
28. ATS Workshop Proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc. 2006;3:131-145.
29. Bergeron C, Boulet LP, Page N, et al. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol. 2007;119:391-397.
30. Horváth I, Donnelly LE, Kiss A, Balint B, Kharitonov SA, Barnes PJ. Exhaled nitric oxide and hydrogen peroxide concentration in asthmatic smokers. Respiration. 2004;71:463- 468.
31. Verleden GM, Dupont LJ, Verpeut AC, Demedts MG. The effect of cigarette smoking on exhaled nitric oxide in mild steroid-naïve asthmatics. Chest. 1999;116:59-64.
32. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest. 1997;112:313-318.
33. Lazarus SC, Chinchilli VM, Rollings NJ, et al; National Heart Lung and Blood Institute's Asthma Clinical Research Network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med. 2007;175:783-790.
34. Pietropaloli AP, Perillo IB, Perkins PT, et al. Smokers have reduced nitric oxide production by conducting airways but normal levels in the alveoli. Inhal Toxicol. 2007;19:533-541.
35. 2a reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. Am J Respir Crit Care Med. 1998;158:1374-1378.
36. 2 in the expired breath condensate of patients with asthma. Eur Respir J. 2003;22:743-747.
37. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J. 2005;26:52-59.
38. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med. 2002;165:1364-1370.
39. Paget-Brown AO, Ngamtrakulpanit L, Smith A, et al. Normative data for pH of exhaled breath condensate. Chest. 2006;129:426-430.
40. Sunyer J, Springer G, Jamieson B, et al. Effects of asthma on cell components in peripheral blood among smokers and non-smokers. Clin Exp Allergy. 2003;33:1500-1505.
41. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med. 2006;174:127-133.
42. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol. 1993;108:833-837.
43. Pedersen B, Dahl R, Karlström R, Peterson CG, Venge P. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide: the impact of smoking. Am J Respir Crit Care Med. 1996;153:1519-1529.
44. Mitsunoby F, Ashida K, Hosaki Y, et al. Influence of long-term cigarette smoking on immunoglobulin E-mediated allergy, pulmonary function, and high-resolution computed tomography lung densitometry in elderly patients with asthma. Clin Exp Allergy. 2004;34:59-64.
45. 4 in urine in patients with asthma and COPD: the effect of smoking habit. Respir Med. 2007;101:826-832.
46. Van Hal PT, Overbeek SE, Hoogsteden HC, et al. Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids. J Appl Physiol. 1996;81:548-555.
47. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25:552-563.
48. Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176: 231-237.
49. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest. 2006;130:1541-1546.